Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-01-09 @ 12:55 AM
Study NCT ID:
NCT00675792
Status:
COMPLETED
Last Update Posted:
2015-03-13
First Post:
2008-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Sugammadex Administered at 1-2 Post Tetanic Counts (PTCs) or Better With Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adults Undergoing Elective Open Abdominal Procedure (19.4.334) (P05774)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-07
First Submit QC Date:
None
Study First Post Date:
2008-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-21
Results First Submit QC Date:
None
Results First Post Date:
2013-07-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-10-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-02-24
Last Update Post Date:
2015-03-13
Last Update Post Date Type:
ESTIMATED